To delineate this heterogeneity between primary and recurrent GBM, we have profiled gene expression in glioma-rich and microglia/macrophage-rich spatially defined ROIs using Gfap and Iba1 as the respective visualizing markers. The gene discussed is AIF1; the disease is glioma.